TY - JOUR
AU - R. McDonald
AU - A. B. Bech
AU - T. Clausen
A1 - 
AD - Norwegian Centre for Addiction Research (SERAF), Institute of Clinical Medicine, Oslo University, P.O. Box 1171, Blindern, Oslo, 0318, Norway. rebecca.mcdonald@medisin.uio.no.; Norwegian Centre for Addiction Research (SERAF), Institute of Clinical Medicine, Oslo University, P.O. Box 1171, Blindern, Oslo, 0318, Norway.; Faculty of Social and Health Sciences, Inland University of Applied Sciences, P.O. Box 400 Vestad, Elverum, 2418, Norway.
AN - 37679751
BT - BMC Health Serv Res
C5 - Opioids & Substance Use; HIT & Telehealth; Education & Workforce
CP - 1
DA - Sep 7
DO - 10.1186/s12913-023-09959-7
DP - NLM
ET - 20230907
IS - 1
JF - BMC Health Serv Res
LA - eng
PY - 2023
SN - 1472-6963
SP - 965
ST - Flexible delivery of opioid agonist treatment during COVID-19 in Norway: qualitative and quantitative findings from an online survey of provider experiences
T1 - Flexible delivery of opioid agonist treatment during COVID-19 in Norway: qualitative and quantitative findings from an online survey of provider experiences
T2 - BMC Health Serv Res
TI - Flexible delivery of opioid agonist treatment during COVID-19 in Norway: qualitative and quantitative findings from an online survey of provider experiences
U1 - Opioids & Substance Use; HIT & Telehealth; Education & Workforce
U3 - 10.1186/s12913-023-09959-7
VL - 23
VO - 1472-6963
Y1 - 2023
ER -